Financial statements Warsaw Genomics

Balance sheet of Warsaw Genomics

Company age:
Age:
11 y. 4 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of WARSAW GENOMICS

Year
2018
2019
2020
2021
2022
2023
Total assets 27 440,13 32 928,43 2 012 368,65 3 819 149,59 278 902,31 17 420,31
A. Fixed assets 50,00 50,00 50,00 50,00 2 000,00 0,00
B. Current assets 27 390,13 32 878,43 2 012 318,65 3 819 099,59 276 902,31 17 420,31
C. Share capital contributions (basic funds) 0,00 - - - - -
D. Own shares (stocks) 0,00 - - - - -
Total liabilities 27 440,13 32 928,43 2 012 368,65 3 819 149,59 278 902,31 17 420,31
A. Equity 2 599,13 -1 037,07 1 916 584,34 2 645 384,24 2 503,00 -8 006,00
B. Liabilities and provisions for liabilities 24 841,00 33 965,50 95 784,31 1 173 765,35 276 399,31 25 426,31
I. Long-term liabilities 0,00 - - - - -
II. Short-term liabilities 24 841,00 33 965,50 95 784,31 1 173 765,35 276 399,31 25 426,31
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.